Waters Bioprocessing Walk-Up Solution
Accelerating upstream bioprocessing with rapid processing times.
Is the time it takes to obtain analysis results a bottleneck in the analysis of cell culture media (CCM), clone selection, process development, and optimization? Waters' bioprocessing walk-up solution eliminates that time lag and accelerates your decision-making. Efficient upstream bioprocessing from cell line development (CLD) to upstream process development (USP) requires a high-sensitivity, robust high-throughput analytical platform. This system is an ideal choice for at-line process analytical technology (PAT) that can overcome cumbersome routine measurements of CPP and CQA, with the capability to integrate with bioreactors such as Sartorius Ambr 15 and Ambr 250, achieving the following: ■ Streamlining the workflow from sample pretreatment to data acquisition through data analysis using samples from the bioreactor ■ Generating quantitative analytical results that guide process development (for both CPP and CQA) ■ Enabling faster and more reliable decision-making through high-quality data from samples taken from the bioreactor
- 企業：日本ウォーターズ（米国本社 Waters Corporation）
- 価格：Other
